Clinical relevance of the combined analysis of circulating tumor cells and anti-tumor T-cell immunity in metastatic breast cancer patients

BACKGROUND: Metastatic breast cancer (mBC) is a heterogeneous disease with varying responses to treatments and clinical outcomes, still requiring the identification of reliable predictive biomarkers. In this context, liquid biopsy has emerged as a powerful tool to assess in real-time the evolving la...

Descripción completa

Detalles Bibliográficos
Autores principales: Muraro, Elena, Del Ben, Fabio, Turetta, Matteo, Cesselli, Daniela, Bulfoni, Michela, Zamarchi, Rita, Rossi, Elisabetta, Spazzapan, Simon, Dolcetti, Riccardo, Steffan, Agostino, Brisotto, Giulia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446887/
https://www.ncbi.nlm.nih.gov/pubmed/36081561
http://dx.doi.org/10.3389/fonc.2022.983887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446887/
https://www.ncbi.nlm.nih.gov/pubmed/36081561
http://dx.doi.org/10.3389/fonc.2022.983887

Ejemplares similares